Belzutifan

CHEMBL4585668 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

383.3 g/mol

LogP

2.0

Phase

4

A HIF-2 alpha inhibitor that blocks the transcription factor driving the growth of certain kidney cancers and tumors associated with von Hippel-Lindau disease. It reduces the expression of growth factors that tumors need for angiogenesis.

Moleküler Ağırlık

383,3000 g/mol

LogP

2,00

TPSA

95,80 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Ovarian Cancer Pancreatic Cancer Chronic Kidney Disease Breast Cancer Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F

InChI

InChI=1S/C17H12F3NO4S/c1-26(23,24)12-3-2-11(13-14(12)17(22)16(20)15(13)19)25-10-5-8(7-21)4-9(18)6-10/h2-6,15-17,22H,1H3/t15-,16-,17+/m1/s1

Molecular Formula

C17H12F3NO4S

HBD / HBA

1 / 8

Döndürülebilir Bağlar

3

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A HIF-2 alpha inhibitor that blocks the transcription factor driving the growth of certain kidney cancers and tumors associated with von Hippel-Lindau disease. It reduces the expression of growth factors that tumors need for angiogenesis.

Yes, Belzutifan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4585668. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 117947097. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Belzutifan PillFYI'da

Yapı

Hızlı Veriler

Formül: C17H12F3NO4S
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.